Orfadin® (nitisinone) receives positive opinion from CHMP for treatment of AKU
- Friday, September 18, 2020, 7:12
- PR Newswire
- Add a comment
STOCKHOLM, Sept. 18, 2020 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Orfadin® (nitisinone) for the treatment of adult…
About the Author
admin has written 20652 stories on this site.